Peptide Terms：Signal Peptides?
Peptide Types
Section titled “Peptide Types”Peptide (Amino-acid chain)
Section titled “Peptide (Amino-acid chain)”A short chain of amino acids linked in sequence. In skin-care and research contexts it usually refers to fragments with a molecular weight far below that of a complete protein.
Oligopeptide (Short peptide)
Section titled “Oligopeptide (Short peptide)”Usually 2–10 amino acids. Small molecular weight, favorable for transdermal discussions and oral-absorption research.
Protein (Folded amino-acid chain)
Section titled “Protein (Folded amino-acid chain)”A longer amino-acid chain with complex folding. Dermal-matrix components such as collagen and elastin belong to this level.
Signal peptide (Signaling molecule)
Section titled “Signal peptide (Signaling molecule)”A peptide segment that transmits “synthesis or repair” signals to cells, acting at receptors or integrins rather than directly serving as structural material.
Neurotransmitter-inhibiting peptide (Synaptic-signal inhibitor)
Section titled “Neurotransmitter-inhibiting peptide (Synaptic-signal inhibitor)”Interferes with synaptic-vesicle release or receptor binding, weakening the contraction signal of expression muscles; used in dynamic-wrinkle research.
Carrier peptide (Trace-element carrier)
Section titled “Carrier peptide (Trace-element carrier)”A peptide segment that carries trace elements (such as copper) or supports dermo-epidermal junction (DEJ) repair; GHK-Cu is the typical representative.
Formulation and Specifications
Section titled “Formulation and Specifications”Fixed-ratio blend (Premixed formula)
Section titled “Fixed-ratio blend (Premixed formula)”A product form in which multiple active ingredients are combined at fixed input ratios; the ratios are traceable and the protocol reproducible.
Active ingredient (Bioactive substance)
Section titled “Active ingredient (Bioactive substance)”The substance in a formulation or product that produces the main biological effect.
Lyophilized powder (Freeze-dried powder)
Section titled “Lyophilized powder (Freeze-dried powder)”A solid form produced by low-temperature vacuum drying, favorable for stable storage of peptides; reconstituted before use.
Molecular weight (Physical property)
Section titled “Molecular weight (Physical property)”A key indicator affecting absorption and specifications. Oral oligopeptides are often controlled in 200–2000 Da tiers.
Read more: Skin Repair, Peptide Basics
Read more: Peptide Basics, Fixed-ratio blends, Cosmeceutical peptide ingredients.
Further Reading
Section titled “Further Reading”Compare with Peptide Basics, Fixed-ratio blends, Cosmeceutical peptides. Related review PMID: 41924746.
Comparison Table
Section titled “Comparison Table”| Item | Description |
|---|---|
| Mechanism | See above |
| Entries | See blends |
| References | See individual ingredient entries |
Safety Boundaries and Limitations
Section titled “Safety Boundaries and Limitations”Terminology definitions are for search and translation; they do not constitute usage or dosage instructions. Research peptides and cosmeceutical peptides fall under different regulatory categories.
Key Takeaways
Section titled “Key Takeaways”Core Mechanisms
Section titled “Core Mechanisms”First understand the pathway and the tissue/metabolic background, then cross-check ingredient entries and practical steps; avoid memorizing brand names alone.
Common Misconceptions
Section titled “Common Misconceptions”Treating a single ingredient as a complete protocol; ignoring underlying factors such as sleep, training, and diet; ignoring batch quality (COA).
Next Steps
Section titled “Next Steps”- Cross-check blends to select relevant mechanisms.
- When you need hands-on steps, see Reconstitution and Storage.
- For cross-page terminology, see the Glossary.
Additional Entries
Section titled “Additional Entries”Peptide therapy
Section titled “Peptide therapy”A general term for intervention thinking that uses peptides as the core tool; this site splits it into repair, metabolism, cognition, and other lines, outlined in Peptide Therapy Overview. At the terminology level it describes a concept only — not a protocol or dosage.
Bioavailability
Section titled “Bioavailability”The fraction reaching systemic circulation by a given route; subcutaneous, intranasal, oral, and transdermal differ clearly, compared in Bioavailability. Switching routes for the same molecule means doses do not transfer directly.
Purity
Section titled “Purity”The main component’s share of label claim, commonly expressed as the HPLC main-peak area; not the same metric as assay — see How to Read a COA. Batch-to-batch variation is the QC focus.
Endotoxin
Section titled “Endotoxin”A lipopolysaccharide contamination indicator that injectable-grade research material needs to watch; together with purity it forms the key batch-release items — storage conditions in Storage and Cold Chain.
Specification (Quick Reference)
Section titled “Specification (Quick Reference)”| Term | Relation to specifications | Extension |
|---|---|---|
| Molecular weight | Oral oligopeptides are often banded at 200–2000 Da | Oral Oligopeptides |
| Purity | HPLC main-peak share; report in the COA | How to Read a COA |
| Endotoxin | One of the release items for injectable-grade material | Storage and Cold Chain |
Related Reading
Section titled “Related Reading”- Term cross-checks: Skin Repair, Signaling, Endocrine and Metabolic.
- Practical follow-ups: Reconstitution and Dose Conversion, Administration Routes.
- Ingredient entry points: Peptide Basics, Topical Signal Peptides, Oral Collagen Peptides.